4//SEC Filing
OAKES FRANK R. 4
Accession 0001654954-20-000313
CIK 0001540159other
Filed
Jan 9, 7:00 PM ET
Accepted
Jan 10, 9:42 PM ET
Size
10.0 KB
Accession
0001654954-20-000313
Insider Transaction Report
Form 4
OAKES FRANK R.
DirectorPresident, CEO & Director
Transactions
- Award
Common Shares
2020-01-08$4.11/sh+1,218$5,006→ 1,218 total(indirect: By Trust) - Award
Common Share Warrants (Right to Buy)
2020-01-08+609→ 609 total(indirect: By Trust)Exercise: $4.00From: 2020-07-08Exp: 2020-11-08→ Common Shares (609 underlying) - Award
Common Share Warrants (Right to Buy)
2020-01-08+914→ 914 total(indirect: By Trust)Exercise: $4.80From: 2020-07-08Exp: 2023-07-08→ Common Shares (914 underlying)
Holdings
- 6,165
Common Shares
Footnotes (3)
- [F1]The reported securities are included within 1,218 Common Shares purchased by the reporting person for $4.11 per Common Share. Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share.
- [F2]Consists of Class A Warrants to purchase Common Shares. The Class A Warrants are exercisable beginning on July 8, 2020 and expire on July 8, 2023.
- [F3]Consists of Class B Warrants to purchase Common Shares. The Class B Warrants are exercisable beginning on July 8, 2020 and expire on November 8, 2020.
Documents
Issuer
Edesa Biotech, Inc.
CIK 0001540159
Entity typeother
Related Parties
1- filerCIK 0001620188
Filing Metadata
- Form type
- 4
- Filed
- Jan 9, 7:00 PM ET
- Accepted
- Jan 10, 9:42 PM ET
- Size
- 10.0 KB